role of Dazzle capsule in Rheumatoid arthritis
- Conditions
- Health Condition 1: null- Rheumatoid arthritis
- Registration Number
- CTRI/2016/01/006572
- Lead Sponsor
- Vasu Research Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Presence of any four out of the following seven (Joneâ??s) criteria (according to 1987, revised criteria of American College of Rheumatology)
a. Morning stiffness: Stiffness in and around joints lasting one hour before maximal improvement (More than 6 weekâ??s duration).
b. Arthritis of three or more joints, at least three joint area, observed by scholar, having pain with soft tissue swelling or joint effusion, not just bony over growth, (more than 6 weeks duration).
c. Arthritis of hand joints, at least 1 area in wrist and hand is swollen (more than 6 weeks duration).
d. Symmetric arthritis (more than 6 weekâ??s duration).
e. Presence of Rheumatoid Nodules
f. Serum Rheumatoid factor- positive
g. Typical radiographic changes of arthritis on PA view of hand & wrist radiograph that must include erosions or unequivocal bony decalcification, localized in or adjacent to involved joints.
Patients who have developed complications of Rheumatoid Arthritis e.g. severe deformity of joints / bones, pleura-pericardial disease, or else.
(2) Patients with poorly controlled Hypertension or with uncontrolled Diabetes Mellitus and having a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
(4) Patients on prolonged medication with corticosteroids, antidepressants, anticholinergics, etc. or any other drugs that may have an influence on the outcome of the study.
(5) H/o hypersensitivity to any of the trial drugs or their ingredients.
(6) Pregnant/lactating women.
(7) Patients having chronicity >10 years
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method